Exhibit 10.2 AMENDMENT NO. 1 TO ESCROW AGREEMENT This Amendment No. 1 ("Amendment No. 1") to the Escrow Agreement dated as of November 29, 2001 (the "Agreement") is made and entered into as of November 29, 2001, by and among Endorex Corporation, a...
Exhibit 10.2
AMENDMENT NO. 1
TO
ESCROW AGREEMENT
This Amendment No. 1 ("Amendment No. 1") to the Escrow Agreement dated
as of November 29, 2001 (the "Agreement") is made and entered into as of
November 29, 2001, by and among Endorex Corporation, a Delaware corporation
("Parent"), ▇▇▇▇▇ ▇. ▇▇▇▇▇, as the representative of the stockholders of
Corporate Technology Development, Inc. who are parties to the Agreement (the
"Stockholder Representative"), Paramount Capital Drug Development Holdings LLC
as a stockholder of Corporate Technology Development, Inc. (the "Stockholder"),
and ▇▇▇▇▇ Fargo Bank Minnesota, National Association, a national banking
association, as escrow agent (the "Escrow Agent").
RECITALS
WHEREAS, Parent, certain stockholders of Corporate Technology Development,
Inc., a Delaware corporation, the Stockholder Representative and the Escrow
Agent have entered into the Agreement; and
WHEREAS, Parent, the Stockholder Representative, the Stockholder and the
Escrow Agent desire to amend certain terms of the Agreement pursuant to Section
6.5 thereof.
AGREEMENT
NOW, THEREFORE, in consideration of the premises and the
representations, warranties, covenants and agreements contained herein and in
the Agreement and for other good and valuable consideration, the receipt of
which is hereby acknowledged, the parties hereto agree as follows:
1. Schedule C to the Agreement is hereby be amended and restated in its
entirety as set forth on Schedule 1 attached hereto.
2. All capitalized terms used but not defined herein have the meaning
ascribed to such terms in the Agreement.
3. All terms of the Agreement other than those amended hereby remain in
full force and effect.
* * * * *
IN WITNESS WHEREOF, the parties hereto have caused this Amendment No. 1
to be executed and delivered as of the date first written above.
PARENT:
ENDOREX CORPORATION
/s/ ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇
-------------------------------
By: ▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇
---------------------------
Its: President
--------------------------
STOCKHOLDER REPRESENTATIVE:
/s/ ▇▇▇▇▇ ▇. ▇▇▇▇▇
------------------------------
▇▇▇▇▇ ▇. ▇▇▇▇▇
ESCROW AGENT:
▇▇▇▇▇ FARGO BANK MINNESOTA,
NATIONAL ASSOCIATION, as Escrow Agent
/s/ ▇▇▇▇▇▇ ▇. ▇'▇▇▇▇▇▇▇
-------------------------------
By: ▇▇▇▇▇▇ ▇. ▇'▇▇▇▇▇▇▇
---------------------------
Title: Corporate Trust Officer
------------------------
STOCKHOLDER:
PARAMOUNT CAPITAL DRUG
DEVELOPMENT HOLDINGS LLC
/s/ ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇
--------------------------------
By: ▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇
---------------------------
Its:
---------------------------
Schedule 1
Distributions
1. Common Stock to be distributed by the Escrow Agent to the Stockholder
Representative on or promptly after March 31, 2002 pursuant to Section 3 of
Schedule B:
----------
Stockholder Name Number of shares of Common Stock
TVM Medical Ventures GmbH & Co. KG 101,537
Nomura Bank (Switzerland) Ltd. 90,255
▇▇▇▇ Capital Partners V, L.P. 67,120
Imprimus Investors LLC 37,606
Bristol ▇▇▇▇▇▇▇▇▇▇▇ Investments, L.P. 37,606
▇▇▇▇▇▇▇ Investments, LLC 18,803
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ 15,042
▇▇▇▇▇ Joint Venture, L.P. 15,042
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇, M.D. 13,162
Concordia Partners 11,282
▇. ▇▇▇▇▇▇▇▇▇▇-▇▇▇▇▇▇▇ 11,282
Drax Holdings, L.P. 9,401
▇▇▇▇▇▇▇ ▇▇▇▇ 9,401
▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ 9,401
Keys Foundation, Curacro 9,401
▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ 7,521
▇▇▇▇▇ ▇. ▇▇▇▇▇ 7,521
▇▇▇▇ Capital Partners V (Domestic Annex Fund) L.P. 5,648
▇▇▇▇▇▇ ▇. ▇▇▇▇ 3,760
Caxton Partners 3,760
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ 3,760
The Holding Company 3,760
Seju Suzuki 3,760
▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ 3,760
Asahi Iron Foundry Co., Ltd. 3,760
▇▇▇▇▇▇▇ ▇▇▇▇▇ 3,760
Maidenhair Investments, N.V. 3,760
▇▇▇▇ Capital Partners V International, L.P. 2,444
▇▇▇▇▇ ▇▇▇▇▇ 1,880
▇▇▇▇▇ ▇▇▇▇ P.C. Money Purchase Plan 1,880
▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 1,880
▇▇▇▇▇ ▇▇▇▇ PC Defined Benefit Pension Plan 1,880
▇▇▇▇▇ ▇. ▇▇▇▇ 1,880
Tis Prager 1,316
▇▇▇▇▇ ▇▇▇▇▇▇ 1,316
▇▇▇▇▇ ▇▇▇▇, ▇▇▇ (KC) 940
▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ 470
Paramount Capital Drug Development Holdings LLC 131,277
▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 11,418
▇▇▇▇▇▇▇▇ ▇▇▇▇▇ 5,061
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 5,061
Biotechnology Solutions, LLC 3,191
▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇▇ 1,528
▇▇▇▇▇▇▇ ▇▇▇▇▇ 1,518
▇▇▇▇▇ and ▇▇▇▇▇ ▇▇▇▇ 1,012
Huntington Street Company 1,012
June Street Company 1,012
Kash Family Foundation 810
▇▇▇▇▇ ▇. ▇▇▇▇ 713
▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ 713
▇▇▇▇ ▇▇▇▇▇▇▇▇▇ 688
▇▇▇ ▇▇▇▇▇▇▇▇▇ 688
▇▇▇▇▇▇▇ ▇▇▇▇▇▇ 607
▇▇▇▇ ▇▇▇▇▇▇ 607
American Friends of Hebron Yeshiva in Jerusalem 202
Stockholder Name Number of shares of Common Stock
▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ 202
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 172
▇▇▇▇ ▇▇▇▇ 172
▇▇▇▇▇ ▇. ▇▇▇▇▇ 172
▇▇▇▇ ▇. ▇▇▇▇▇ 172
▇▇▇▇ ▇▇▇▇▇▇▇▇ 101
▇▇▇▇▇▇ ▇▇▇▇▇ 101
▇▇▇▇▇▇ ▇▇▇▇▇▇ 101
2. Common Stock to be distributed by the Escrow Agent to the Stockholder
Representative on or promptly after September 30, 2002 pursuant to Section 4
of Schedule B:
----------
Stockholder Name Number of shares of Common Stock
TVM Medical Ventures GmbH & Co. KG 50,769
Nomura Bank (Switzerland) Ltd. 45,128
▇▇▇▇ Capital Partners V, L.P. 33,560
Imprimus Investors LLC 18,803
Bristol ▇▇▇▇▇▇▇▇▇▇▇ Investments, L.P. 18,803
▇▇▇▇▇▇▇ Investments, LLC 9,401
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ 7,521
▇▇▇▇▇ Joint Venture, L.P. 7,521
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇, M.D. 6,581
Concordia Partners 5,641
▇. ▇▇▇▇▇▇▇▇▇▇-▇▇▇▇▇▇▇ 5,641
Drax Holdings, L.P. 4,701
▇▇▇▇▇▇▇ ▇▇▇▇ 4,701
▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ 4,701
Keys Foundation, Curacro 4,701
▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ 3,761
▇▇▇▇▇ ▇. ▇▇▇▇▇ 3,761
▇▇▇▇ Capital Partners V (Domestic Annex Fund) L.P. 2,824
▇▇▇▇▇▇ ▇. ▇▇▇▇ 1,880
Caxton Partners 1,880
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ 1,880
The Holding Company 1,880
Seju Suzuki 1,880
▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ 1,880
Asahi Iron Foundry Co., Ltd. 1,880
▇▇▇▇▇▇▇ ▇▇▇▇▇ 1,880
Maidenhair Investments, N.V. 1,880
▇▇▇▇ Capital Partners V International, L.P. 1,222
▇▇▇▇▇ ▇▇▇▇▇ 940
▇▇▇▇▇ ▇▇▇▇ P.C. Money Purchase Plan 940
▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 940
▇▇▇▇▇ ▇▇▇▇ PC Defined Benefit Pension Plan 940
▇▇▇▇▇ ▇. ▇▇▇▇ 940
Tis Prager 658
▇▇▇▇▇ ▇▇▇▇▇▇ 658
▇▇▇▇▇ ▇▇▇▇, ▇▇▇ (KC) 470
▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ 235
Paramount Capital Drug Development Holdings LLC 45,550
▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 5,709
▇▇▇▇▇▇▇▇ ▇▇▇▇▇ 2,530
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 2,530
Biotechnology Solutions, LLC 1,596
▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇▇ 764
▇▇▇▇▇▇▇ ▇▇▇▇▇ 759
▇▇▇▇▇ and ▇▇▇▇▇ ▇▇▇▇ ▇▇▇
▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ Company ▇▇▇
▇▇▇▇ ▇▇▇▇▇▇ Company 506
Kash Family Foundation 405
▇▇▇▇▇ ▇. ▇▇▇▇ 357
Stockholder Name Number of shares of Common Stock
▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ 357
▇▇▇▇ ▇▇▇▇▇▇▇▇▇ 344
▇▇▇ ▇▇▇▇▇▇▇▇▇ 344
▇▇▇▇▇▇▇ ▇▇▇▇▇▇ 304
▇▇▇▇ ▇▇▇▇▇▇ 304
American Friends of Hebron Yeshiva in Jerusalem 101
▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ 101
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 86
▇▇▇▇ ▇▇▇▇ 86
▇▇▇▇▇ ▇. ▇▇▇▇▇ 86
▇▇▇▇ ▇. ▇▇▇▇▇ 86
▇▇▇▇ ▇▇▇▇▇▇▇▇ 50
▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇
▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇
▇. Common Stock to be distributed by the Escrow Agent to the Stockholder
Representative on or promptly after March 31, 2003 pursuant to Section 5 of
Schedule B:
----------
Stockholder Name Number of shares of Common Stock
TVM Medical Ventures GmbH & Co. KG 50,769
Nomura Bank (Switzerland) Ltd. 45,128
▇▇▇▇ Capital Partners V, L.P. 33,560
Imprimus Investors LLC 18,804
Bristol ▇▇▇▇▇▇▇▇▇▇▇ Investments, L.P. 18,804
▇▇▇▇▇▇▇ Investments, LLC 9,402
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇ 7,522
▇▇▇▇▇ Joint Venture, L.P. 7,522
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇, M.D. 6,581
Concordia Partners 5,641
▇. ▇▇▇▇▇▇▇▇▇▇-▇▇▇▇▇▇▇ 5,641
Drax Holdings, L.P. 4,701
▇▇▇▇▇▇▇ ▇▇▇▇ 4,701
▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇ 4,701
Keys Foundation, Curacro 4,701
▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇ 3,761
▇▇▇▇▇ ▇. ▇▇▇▇▇ 3,761
▇▇▇▇ Capital Partners V (Domestic Annex Fund) L.P. 2,825
▇▇▇▇▇▇ ▇. ▇▇▇▇ 1,881
Caxton Partners 1,881
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇▇▇ 1,881
The Holding Company 1,881
Seju Suzuki 1,881
▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇ 1,881
Asahi Iron Foundry Co., Ltd. 1,881
▇▇▇▇▇▇▇ ▇▇▇▇▇ 1,881
Maidenhair Investments, N.V. 1,881
▇▇▇▇ Capital Partners V International, L.P. 1,223
▇▇▇▇▇ ▇▇▇▇▇ 941
▇▇▇▇▇ ▇▇▇▇ P.C. Money Purchase Plan 941
▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 941
▇▇▇▇▇ ▇▇▇▇ PC Defined Benefit Pension Plan 941
▇▇▇▇▇ ▇. ▇▇▇▇ 941
Tis Prager 658
▇▇▇▇▇ ▇▇▇▇▇▇ 658
▇▇▇▇▇ ▇▇▇▇, ▇▇▇ (KC) 470
▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ 235
Paramount Capital Drug Development Holdings LLC 45,551
▇▇▇▇▇ ▇. ▇▇▇▇▇▇ 5,710
▇▇▇▇▇▇▇▇ ▇▇▇▇▇ 2,531
▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 2,531
Biotechnology Solutions, LLC 1,596
▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇▇▇ 765
Stockholder Name Number of shares of Common Stock
▇▇▇▇▇▇▇ ▇▇▇▇▇ 760
▇▇▇▇▇ and ▇▇▇▇▇ ▇▇▇▇ ▇▇▇
▇▇▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ Company ▇▇▇
▇▇▇▇ ▇▇▇▇▇▇ Company 506
Kash Family Foundation 405
▇▇▇▇▇ ▇. ▇▇▇▇ 357
▇▇▇▇▇▇▇ ▇▇▇▇▇▇▇ 357
▇▇▇▇ ▇▇▇▇▇▇▇▇▇ 345
▇▇▇ ▇▇▇▇▇▇▇▇▇ 345
▇▇▇▇▇▇▇ ▇▇▇▇▇▇ 304
▇▇▇▇ ▇▇▇▇▇▇ 304
American Friends of Hebron Yeshiva in Jerusalem 102
▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇▇ 102
▇▇▇▇▇▇ ▇. ▇▇▇▇▇▇▇ 86
▇▇▇▇ ▇▇▇▇ 86
▇▇▇▇▇ ▇. ▇▇▇▇▇ 86
▇▇▇▇ ▇. ▇▇▇▇▇ 86
▇▇▇▇ ▇▇▇▇▇▇▇▇ 51
▇▇▇▇▇▇ ▇▇▇▇▇ ▇▇
▇▇▇▇▇▇ ▇▇▇▇▇▇ 51